Want to join the conversation?
$EFX 2Q15 Q&A: Andre Benjamin from Goldman Sachs hoping to get some color on verification. Rick answers, thinking about the growth on verification side, as you continue to add a records, that's all incremental revenue right there and they have been adding records for a long time now.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.